Komori
Medical Ikkou Group (3353) · PolicyRaisedLatest Dividends (2026-09-30): "Restated"

Stable and Consistent Dividend Policy

First written in FY2018. 4 of 9 entries say "Restated". Latest entry: 2026-09-30.

9entries
9years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018 – FY20232018: 120182019: 120192020: 020202021: 020212022: 020222023: 120232024: 020242025: 120252026: 52026
Same theme, other companies
Policy of steady, continuous shareholder returns and dividend increasesA theme 1084 companies write about · 2 as a headwind · 1108 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 193 companies compared. The sentences above are computed from all 193.Comparing 200 of the theme's 1109 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-09-30RestatedDividends

    「今中期経営計画期間（2026 年２月期から 2028 年２月期まで）におきましては、配当性向 35％以上を目指すこととしております。」

    中期経営計画期間における配当性向35％以上の方針を再掲し、中間配当を直近の配当予想どおり1株当たり60円と決定している。方針や配当額に実質的な変更はない。
  2. FY2026RaisedAnnual report

    「Taking comprehensive account of current-period business performance and the funds required for future business development, we aim for a dividend payout ratio of at least 35%.」

    The company has raised its numerical target from its previous policy of using a 20% dividend payout ratio as a benchmark to a policy of aiming for a dividend payout ratio of at least 35%.
  4. FY2025ReframedAnnual report

    「Our basic policy is to pay dividends at a payout ratio of approximately 20%, taking comprehensive account of current-period business performance and the funds required for future business development.」

    In addition to its previous policy of stable and continuous dividends, the company has stated a specific benchmark of a 20% dividend payout ratio.
  5. FY2023RestatedAnnual report

    「Our basic policy is to make stable and continuous distributions to shareholders, taking comprehensive account of business performance and the funds required for future business development.」

    The company continues to state its policy of paying stable and continuous dividends while taking business performance and funds for future business into account.
  6. FY2019RestatedAnnual report

    「Our basic policy is to make stable and continuous distributions to shareholders, taking comprehensive account of business performance and the funds required for future business development.」

    The company has reiterated its policy of paying stable and continuous dividends while taking business performance and funds for future business into account.
  7. FY2018First statedAnnual report

    「Our basic policy is to make stable and continuous distributions to shareholders, taking comprehensive account of business performance and the funds required for future business development.」

    The company has stated a policy of maintaining stable and continuous dividends while taking business performance and funds for future business into account.
Moved together

"Profit Pressure from Intensifying Price Competition in the Pharmaceutical Wholesale Market" moved the same way as this thread, in the same document, in 2 of its 9 moves.

22★12
  1. ★This thread
  2. 1Profit Pressure from Intensifying Price Competition in the Pharmaceutical Wholesale Market2×
  3. 2Impairment Risk for Fixed Assets and Goodwill2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Medical Ikkou Group yet. It last moved in the Dividends of 2026-09-30: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Stable and Consistent Dividend Policy | Medical Ikkou Group Co.,Ltd. (3353) | Komori